The role of FUBP3 has not been characterized in leukaemia, and to comprehend the same, FUBP3‐siRNA mediated knockdown experiments were performed in K562 cells to mimic the conditions in CML samples. This evidence concerns the gene FUBP3 and chronic myelogenous leukemia, BCR-ABL1 positive.